LEAP Technologies and Antec start collaboration

LEAP Technologies and Antec start collaboration

June 01, 2016

LEAP Technologies Inc. (LEAP), Carrboro, NC, USA and Antec, Zoeterwoude, The Netherlands, announced their collaboration in the field of sample preparation for HDX/MS.

LEAP is a provider of automated Hydrogen Deuterium Exchange (HDX) workstations that allow for labeling, quenching and injection of protein samples under cold conditions. Antec is a provider of the ROXY electrochemical system, providing fast and efficient electrochemical reduction of disulfide bonds in proteins/peptides. The integration the ROXY EC system into LEAP’s PAL HDX workstation will assure a fully automated HDX/EC/MS workflow which can be used with every mass spectrometer.

The full integration enables reducing disulfide bonds in proteins/peptides in only a fraction of the time compared with the use of reducing agents (TCEP). Large and highly disulfide-stabilized proteins (e.g., cystine knots) previously difficult to reduce chemically are now accessible for HDX, resulting in an overall increased sequence coverage. Jean-Pierre Chervet (CEO Antec) comments: we are excited to collaborate with LEAP the world leader in HDX automation and to bring HDX/MS to a new level of customer satisfaction by integrating the disulfide bond reduction.

LEAP and Antec are proud to be providing an improved customer solution of HDX/EC/MS integration.

At ASMS, June 5-9, 2016, both companies will present this approach.

For more information feel free to visit Antec booth # 700 or LEAP Technologies booth # 623. LEAP is part of the Trajan family - you can also meet the team from Trajan Scientific and Medical at booth # 403.

Download
Press Release [PDF]

More information
www.myantec.com
www.leaptec.com
www.asms.org




Also in News

Trajan acquires personalised blood testing business to strengthen move into data-based preventative healthcare
Trajan acquires personalised blood testing business to strengthen move into data-based preventative healthcare

April 16, 2021

Trajan Scientific and Medical (Trajan) has completed the acquisition of the MyHealthTest blood testing service for an undisclosed sum. The acquisition further boosts Trajan’s ability to deliver analytical measurement services to society at a time when preventative healthcare strategies are becoming increasingly important.

Read More

Close-up of the LLE mixer tool on the Trajan Automation autosampler
Trajan’s “Lab-in-a-Syringe” product development program promises greater laboratory efficiencies

March 30, 2021

Trajan Scientific and Medical’s (Trajan) highly successful ASTech1 program has resulted in the commercial development of several new syringe technologies. The program was developed in collaboration with the University of Tasmania where the objective was to develop a range of “lab-in-a-syringe” applications, expanding on Trajan’s expertise in precision manufacturing of their industry leading analytical syringe portfolio.

Read More

Trajan takes 100% ownership of nutritional testing joint venture and commences expansion of Melbourne laboratories to provide broader analytical services
Trajan takes 100% ownership of nutritional testing joint venture and commences expansion of Melbourne laboratories to provide broader analytical services

March 02, 2021

In 2017 the joint venture between Trajan Scientific and Medical (Trajan) and leading experts in the field of nutrition, Professors Maria Makrides and Robert Gibson was established as Trajan Nutrition. The initial focus of Trajan Nutrition was to improve the health of mothers and their children through the provision of information to support the development of a personalized dietary pathway to better health. This still remains an important element of Trajan Nutrition’s work.

Read More